Search the Newsreel

KTOS Stock In Spotlight: Analyst Sees 37% Upside On Pentagon’s Defense Spending Momentum

Kratos Defense & Security Solutions Inc (KTOS) Shares Surge 5.8% -- What GF Score of 69 Tells Investors

Kratos Defense & Security Solutions Inc (KTOS) shares surged 5.8% to $60.77, despite GuruFocus indicating a "Significantly Overvalued" status with a GF Value™ of $31.92 and a GF Score™ of 69/100. The company shows strong growth potential but significant overvaluation, and insider selling without …

Definitive Healthcare Set to Report Q2 With GF Value Pointing to 520% Upside

Definium Therapeutics (NASDAQ: DFTX) builds $1.1B cash war chest as Phase 3 data hit

Definium Therapeutics reported a Q2 2026 net loss of $158.986 million and a six-month net loss of $236.1 million, despite building a substantial cash reserve of $1.1 billion. This strong liquidity position, largely due to an $805 million equity offering in June 2026, is …

KTOS Q2 Earnings Call Highlights Hypersonics and Engine Ramp-Up

Earnings To Watch: Definitive Healthcare Corp (DH) Q2 2026 -- GF Value Sees 520% Upside

Kratos sees hypersonics revenue reaching at least $700 million in 2027, with MACH-TB funding and new awards driving expansion

Kratos Defense & Security Solutions anticipates its hypersonics business will generate $400 million in revenue in 2026 and at least $700 million in 2027, a significant increase from $200 million in 2025. This growth is driven by new program awards, increased U.S. government funding, …

Paras Defence approves sale of Krasny stake to Krasny Defence Technologies

Paras Defence Q1 results: Net profit grows 40% YoY; board fixes record date for dividend payout

Definium Therapeutics, Inc. Q2 2026: Net loss $(159.0)M, Diluted loss per share $(1.44) — 10-Q Summary

Definium Therapeutics, Inc. reported a significant increase in net loss for Q2 2026, reaching $(159.0)M compared to $(42.7)M in Q2 2025, with diluted loss per share rising to $(1.44). The company had no reported revenue but highlighted several clinical and regulatory advancements including fully …

Earnings call transcript: Definium Therapeutics posts wider Q2 2026 loss as stock rises

Definium Therapeutics reported a wider net loss of $159 million in Q2 2026, primarily due to an $86.2 million non-cash warrant revaluation charge, even as its stock rose. The company increased R&D and G&A expenses to support late-stage trials for its lead drug DT120 …

Earnings Flash (DFTX) Definium Therapeutics Posts Q2 EPS -$1.44, vs. FactSet Est of -$0.54

Definium Therapeutics (DFTX) reported a Q2 EPS of -$1.44, significantly missing the FactSet estimate of -$0.54. The company's Q2 loss widened, as announced on August 6, 2026, alongside their earnings call. Definium Therapeutics focuses on developing treatments for psychiatric and neurological disorders, with its …

Kratos Defense & Security Solutions (NASDAQ:KTOS) Trading Up 3.7% Following Analyst Upgrade

Kratos Defense & Security Solutions (NASDAQ:KTOS) saw its shares rise 3.7% after BTIG Research increased its price target to $104 and maintained a Buy rating. The company reported strong Q2 2026 results with adjusted EPS of $0.21 and revenue of $458.8 million, a 30.5% …

Definium Therapeutics (NASDAQ:DFTX) Slides After Q2 Loss Misses Estimates on Warrant Charge

Definium Therapeutics (NASDAQ:DFTX) reported a Q2 net loss of $1.44 per share, significantly missing the $0.56 consensus estimate, causing shares to fall by about 4.7% after-market. The large loss was primarily due to an $86.2 million non-cash charge from warrant liabilities, although operating losses …

Definium Therapeutics (NASDAQ: DFTX) grows cash to $1.1B, Q2 loss deepens

Definium Therapeutics reported its Q2 2026 financial results, showing a deepened net loss of $159.0 million, primarily due to an $86.2 million non-cash increase in warrant liabilities. Despite the loss, the company significantly increased its cash and investments to $1.1 billion, fueled by an …

Definium Therapeutics Doles Out Inducement Options to New Staff Ahead of Q2 Report

Definium Therapeutics has granted stock options to six new non-executive employees, allowing them to purchase 115,600 common shares with a four-year vesting period. This move, made under its 2026 Inducement Plan, aims to attract talent as the company advances its late-stage psychedelic-based therapies. The …

Definium Therapeutics Q2 Loss Widens

Definium Therapeutics Inc. (DFTX) reported a wider loss in Q2 2026, posting an EPS of -$1.44, which was significantly below FactSet's estimate of -$0.54. The company, formerly Mind Medicine (MindMed) Inc., is focused on developing therapeutics for psychiatric and neurological disorders and is advancing …

Kratos Defense & Security Solutions Inc (KTOS) EVP & CFO Deanna Lund Sells 5,000 Shares

Deanna Lund, EVP and CFO of Kratos Defense & Security Solutions Inc (KTOS), sold 5,000 shares of the company's stock for approximately $242,750. This sale is part of a broader trend of significant insider selling at Kratos, with 93 insider sells and zero buys …

Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform

Definitive Healthcare (Nasdaq: DH) has announced an early adopter program for its new AI-powered healthcare intelligence platform, providing select organizations with early access. The platform integrates claims, provider, consumer, and expert data with conversational AI to surface insights, optimize market opportunities, and improve decision-making. …

Stifel cuts Kratos Defense stock price target on FX headwinds

Stifel lowered its price target for Kratos Defense & Security Solutions (NASDAQ:KTOS) to $115 from $134, while maintaining a Buy rating, citing foreign exchange headwinds despite strong Q2 results. The company exceeded revenue expectations and raised its revenue guidance, driven by significant organic growth …

Kratos Defense EVP & CFO Deanna Lund sells $242,771 in stock

Deanna H. Lund, EVP and CFO of Kratos Defense & Security Solutions, sold 5,000 shares of company stock worth $242,771 on August 3, 2026, under a pre-arranged trading plan. Following the sale, Ms. Lund directly holds 280,487 shares. This comes after Kratos Defense reported …

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) Given Consensus Rating of "Buy" by Analysts

Analysts have given Kratos Defense & Security Solutions (NASDAQ:KTOS) a consensus "Buy" rating, with an average 12-month price target of $102.41. This positive sentiment follows the company's strong second-quarter results, which exceeded expectations in both EPS and revenue, leading management to raise its full-year …

Definity Financial Stock Faces Pressure as Insurance Sector Uncertainty Weighs on Investor Confidence

liberty defense holdings ltd Earnings dates

This article provides the earnings dates and estimates for Liberty Defense Holdings Ltd (SCAN.V, DETX). It lists the Q1 2026 earnings as announced on June 1, 2026, and the Full Year earnings as announced on April 30, 2026. The financial data includes company guidance, …

Kratos Defense & Security Solutions, Inc. Stock 12‑Month Price Target Cut to $105.32, Implies 103% Upside

The average 12-month price target for Kratos Defense & Security Solutions, Inc. (KTOS) stock has been slightly reduced from $106.05 to $105.32 by 22 analysts, yet this still suggests a significant 103% potential upside from its August 4th closing price. The consensus rating among …

Kratos (KTOS) Stock Reprices Higher As Growth Strengthens And Cash Burns

Kratos Defense & Security Solutions (KTOS) saw its stock jump 6.7% after reporting Q2 2026 earnings, with revenue of US$458.8m exceeding guidance due to strong organic growth in hypersonics, engines, and unmanned systems. Despite this positive growth and program execution, concerns remain about cash …

DeFi Dev Corp Backs Solana Upgrades as Analysts Predicts SOL Price to $250

DeFi Dev Corp has announced its support for two Solana crypto upgrade proposals, SIMD-0550 and SIMD-0553, aimed at reducing SOL supply and increasing token burns to improve the network's economic model. While a market analyst predicts SOL could return to $250 based on past …

KTOS Stock Hits Two-Month High As Clear Growth Prospects Spur Piper Sandler Ratings Upgrade

Kratos Defense & Security Solutions (KTOS) stock jumped to a two-month high following an upgrade from Piper Sandler to Overweight, with a $75 price target. The upgrade comes after a 43% decline from its 52-week peak and is supported by Kratos raising its full-year …

Insider Selling: Definity Financial (TSE:DFY) Insider Sells 4,800 Shares of Stock

Kratos Defense upgraded at Piper Sandler on buying opportunity (KTOS:NASDAQ)

Piper Sandler upgraded Kratos Defense & Security Solutions (KTOS) due to the company's significant share-price decline creating an attractive buying opportunity. The investment bank expressed growing confidence in Kratos' production pipeline, revenue outlook, and valuation. Key growth drivers include the MACH-TB hypersonic test vehicle, …

Kratos Defense & Security Solutions (KTOS) Could Be 65% Below Fair Value On Raised 2026 Outlook

Kratos Defense & Security Solutions (KTOS) reported strong Q2 2026 results, surpassing revenue and adjusted EBITDA expectations, and subsequently raised its full-year guidance. Despite recent short-term share price gains, the stock has experienced weakness year-to-date, but a narrative-driven fair value estimate of $150 suggests …

Kratos Defense & Security Solutions Sees Unusually High Options Volume (NASDAQ:KTOS)

Kratos Defense & Security Solutions (NASDAQ:KTOS) experienced unusually high options trading volume, with investors purchasing 13,877 call options, a 37% increase over the daily average. This surge follows strong quarterly results where revenue increased 30.5% year over year to $458.8 million and EPS of …

Liberty Defense Announces Leadership Change

Liberty Defense Holdings Ltd. announced a leadership change, with Bryan Cunningham, President, leaving the company to return to his privacy and advocacy work, effective July 22, 2026. CEO Bill Frain acknowledged Cunningham's contributions and stated that the company does not plan to immediately fill …

Kratos Defense & Security Solutions (NASDAQ:KTOS) Shares Gap Up Following Earnings Beat

Kratos Defense & Security Solutions (NASDAQ:KTOS) shares gapped up by 8.9% following a significant earnings beat, with quarterly EPS of $0.21 exceeding the $0.14 consensus and revenue rising 30.5% to $458.8 million. The company's management maintained an optimistic outlook, projecting 2026 revenue of $1.8 …

Liberty Defense President Leaves to Return to Privacy Advocacy

Liberty Defense (NASDAQ: DETX) announced that its President, Bryan Cunningham, departed on July 22, 2026, to resume his privacy and advocacy work. The company does not plan to immediately fill the position, with CEO Bill Frain stating that the leadership team remains focused on …

Liberty Defense (DETX) president departs as company affirms strategy

Liberty Defense Holdings Ltd. (NASDAQ: DETX) announced that its President, Bryan Cunningham, departed the company effective July 22, 2026, to return to his privacy and advocacy work. The company does not plan to immediately fill the position, with CEO Bill Frain affirming that Liberty …